Подписаться
Dominique Leboeuf
Dominique Leboeuf
Подтвержден адрес электронной почты в домене skoltech.ru
Название
Процитировано
Процитировано
Год
Neuron-derived semaphorin 3A is an early inducer of vascular permeability in diabetic retinopathy via neuropilin-1
A Cerani, N Tetreault, C Menard, E Lapalme, C Patel, N Sitaras, ...
Cell metabolism 18 (4), 505-518, 2013
1522013
Neuronal ER stress impedes myeloid-cell-induced vascular regeneration through IRE1α degradation of netrin-1
F Binet, G Mawambo, N Sitaras, N Tetreault, E Lapalme, S Favret, ...
Cell metabolism 17 (3), 353-371, 2013
902013
Do estrogens impact adolescent idiopathic scoliosis?
D Leboeuf, K Letellier, N Alos, P Edery, F Moldovan
Trends in Endocrinology & Metabolism 20 (4), 147-152, 2009
872009
Computationally guided high-throughput design of self-assembling drug nanoparticles
D Reker, Y Rybakova, AR Kirtane, R Cao, JW Yang, N Navamajiti, ...
Nature nanotechnology 16 (6), 725-733, 2021
702021
Deficiency in the metabolite receptor SUCNR1 (GPR91) leads to outer retinal lesions
S Favret, F Binet, E Lapalme, D Leboeuf, J Carbadillo, T Rubic, E Picard, ...
Aging (Albany NY) 5 (6), 427, 2013
412013
lncRNA in the liver: Prospects for fundamental research and therapy by RNA interference
EM Smekalova, YV Kotelevtsev, D Leboeuf, EY Shcherbinina, AS Fefilova, ...
Biochimie 131, 159-172, 2016
352016
TCR triggering modulates the responsiveness and homeostatic proliferation of CD4+ thymic emigrants to IL-7 therapy
O Hennion-Tscheltzoff, D Leboeuf, SD Gauthier, M Dupuis, B Assouline, ...
Blood 121 (23), 4684-4693, 2013
242013
Downregulation of the Arg/N-degron pathway sensitizes cancer cells to chemotherapy in vivo
D Leboeuf, T Abakumova, T Prikazchikova, L Rhym, DG Anderson, ...
Molecular therapy 28 (4), 1092-1104, 2020
232020
Homeostatic cytokines in immune reconstitution and graft-versus-host disease
S Thiant, MM Moutuou, D Leboeuf, M Guimond
Cytokine 82, 24-32, 2016
202016
Evaluation of cytosine base editing and adenine base editing as a potential treatment for alpha-1 antitrypsin deficiency
MS Packer, V Chowdhary, G Lung, LI Cheng, Y Aratyn-Schaus, ...
Molecular Therapy 30 (4), 1396-1406, 2022
172022
Stromal-Derived Factor-1α and Interleukin-7 Treatment Improves Homeostatic Proliferation of Naïve CD4+ T Cells after Allogeneic Stem Cell Transplantation
SD Gauthier, D Leboeuf, R Manuguerra-Gagné, L Gaboury, M Guimond
Biology of Blood and Marrow Transplantation 21 (10), 1721-1731, 2015
172015
Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients
S Thiant, MM Moutuou, P Laflamme, RS Boumedine, DM Leboeuf, ...
Blood cancer journal 7 (4), e551, 2017
132017
IL-7 Is the Limiting Homeostatic Factor that Constrains Homeostatic Proliferation of CD8+ T Cells after Allogeneic Stem Cell Transplantation and Graft-versus-Host Disease
SD Gauthier, MM Moutuou, F Daudelin, D Leboeuf, M Guimond
Biology of Blood and Marrow Transplantation 25 (4), 648-655, 2019
92019
The Arg/N-Degron Pathway—A Potential Running Back in Fine-Tuning the Inflammatory Response?
D Leboeuf, M Pyatkov, TS Zatsepin, K Piatkov
Biomolecules 10 (6), 903, 2020
62020
Cytosine base editing inhibits Hepatitis B Virus replication and reduces HBsAg expression in vitro and in vivo
E Smekalova, MG Martinez, E Combe, S Dejene, M Packer, D LeBoeuf, ...
4*
Novel Apoptotic Mediators Identified by Conservation of Vertebrate Caspase Targets
N Gubina, D Leboeuf, K Piatkov, M Pyatkov
Biomolecules 10 (4), 612, 2020
32020
Studying Peripheral T Cell Homeostasis in Mice: A Concise Technical Review
MM Moutuou, SD Gauthier, N Chen, D Leboeuf, M Guimond
T-Cell Receptor Signaling: Methods and Protocols, 267-283, 2020
22020
Ubiquitin ligases: a new target for RNAi therapy of hepatocellular carcinoma
D Leboeuf, T Zatsepin, DG Anderson, K Piatkov
Cancer Research 77 (13_Supplement), 3131-3131, 2017
12017
Optimized Base Editing Reagents Yield More Potent Genetic Correction in a Mouse Model of Alpha-1 Antitrypsin Deficiency
MS Packer, D Leboeuf, LI Cheng, R Yang, J Decker, M Otero, LA Barrera, ...
MOLECULAR THERAPY 30 (4), 117-118, 2022
2022
Single, Systemic Administration of BEAM-301 Mitigates Fasting Hypoglycemia and Restores Metabolic Function in a Transgenic Mouse Model of Glycogen Storage Disease Type Ia
Y Aratyn-Schaus, I Arnaoutova, D Leboeuf, TP Fernandez, T Leete, ...
MOLECULAR THERAPY 30 (4), 42-43, 2022
2022
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20